Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Livowin is an Ayurvedic hepatoprotective formulation developed by Stadchem. It is available as a syrup and capsule, containing a synergistic blend of traditional herbs including Kalmegh (Andrographis paniculata), Triphala (Amla, Haritaki, and Bibhitaki), Neem (Azadirachta indica), Bhringaraj (Eclipta alba), Bhuiamlaki (Phyllanthus niruri), Ashwagandha (Withania somnifera), and Arjuna (Terminalia arjuna). Livowin is indicated for the management of various liver disorders, supporting liver detoxification, improving liver function, stimulating bile secretion, and protecting hepatocytes from toxins and oxidative stress. It also aids in digestion and appetite stimulation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Livowin.